4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-029899
SVP, COO & CFO sold 17,448 shares at $3.95 ($68,920)
- SVP, COO & CFO acquired 28,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Labrucherie Gil M · SVP, COO & CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-15 | Grant or award : show line 1 in the form | +28,750 | 330,353 | D | ||
| 2022-05-16 | Sale : show line 2 in the form | −17,448 | $3.95 | $68,920 | 312,905 | D |
| Open-market sales · 17,448 sh · avg $3.95 · $68,920 | ||||||
Loading xslF345X03/doc4.xml…